| Marco Cantini, | |
|
121 W 2nd Ave, 7th Floor, Latrobe, PA 15650-1068 | |
| (724) 537-1230 | |
| Not Available |
| Full Name | Marco Cantini |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 40 Years |
| Location | 121 W 2nd Ave, Latrobe, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912982984 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | MD048838L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Upmc Somerset | Somerset, PA | Hospital |
| Excela Health - Frick Hospital | Mount pleasant, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Upmc Somerset | 1355235144 | 14 |
| Excela Health Physician Practices, Inc | 6204737117 | 438 |
News Archive
Tianyin Pharmaceutical Co., Inc., a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine, branded generics and active pharmaceutical ingredients today announced the approval of the Company's operating subsidiary, Chengdu Tianyin Pharmaceutical Co., Ltd's application for the renewal of its High Tech Enterprise Status in Chengdu, Sichuan Province of China.
When will men have their own birth control pill? Scientists have been predicting the debut of a male pill within 5 years for the last 30 years. The factors accounting for that delay - and new optimism that a male pill will emerge within a decade - are the topic of a story in the current edition of Chemical & Engineering News. C&EN is the weekly newsmagazine of the American Chemical Society, the world's largest scientific society.
Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that the National Institute of Allergy and Infectious Diseases has exercised its option to advance the development of Soligenix's heat stabilized ricin toxin vaccine, RiVax.
School closures due to the COVID-19 pandemic disrupted access to low or no-cost school breakfast and lunch programs for millions of low-income children.
As part of an initiative to give back to the cancer communities in the cities visited during its annual scientific meetings, the American Society for Radiation Oncology (ASTRO) is partnering with the Surviving And Moving Forward: The SAMFund for Young Adult Survivors of Cancer to raise awareness of cancer survivorship issues.
› Verified 4 days ago
| Entity Name | Geisinger Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366493868 PECOS PAC ID: 5395657001 Enrollment ID: O20040130000518 |
News Archive
Tianyin Pharmaceutical Co., Inc., a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine, branded generics and active pharmaceutical ingredients today announced the approval of the Company's operating subsidiary, Chengdu Tianyin Pharmaceutical Co., Ltd's application for the renewal of its High Tech Enterprise Status in Chengdu, Sichuan Province of China.
When will men have their own birth control pill? Scientists have been predicting the debut of a male pill within 5 years for the last 30 years. The factors accounting for that delay - and new optimism that a male pill will emerge within a decade - are the topic of a story in the current edition of Chemical & Engineering News. C&EN is the weekly newsmagazine of the American Chemical Society, the world's largest scientific society.
Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that the National Institute of Allergy and Infectious Diseases has exercised its option to advance the development of Soligenix's heat stabilized ricin toxin vaccine, RiVax.
School closures due to the COVID-19 pandemic disrupted access to low or no-cost school breakfast and lunch programs for millions of low-income children.
As part of an initiative to give back to the cancer communities in the cities visited during its annual scientific meetings, the American Society for Radiation Oncology (ASTRO) is partnering with the Surviving And Moving Forward: The SAMFund for Young Adult Survivors of Cancer to raise awareness of cancer survivorship issues.
› Verified 4 days ago
| Entity Name | University Of Pittsburgh Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619935004 PECOS PAC ID: 8729990239 Enrollment ID: O20040308000883 |
News Archive
Tianyin Pharmaceutical Co., Inc., a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine, branded generics and active pharmaceutical ingredients today announced the approval of the Company's operating subsidiary, Chengdu Tianyin Pharmaceutical Co., Ltd's application for the renewal of its High Tech Enterprise Status in Chengdu, Sichuan Province of China.
When will men have their own birth control pill? Scientists have been predicting the debut of a male pill within 5 years for the last 30 years. The factors accounting for that delay - and new optimism that a male pill will emerge within a decade - are the topic of a story in the current edition of Chemical & Engineering News. C&EN is the weekly newsmagazine of the American Chemical Society, the world's largest scientific society.
Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that the National Institute of Allergy and Infectious Diseases has exercised its option to advance the development of Soligenix's heat stabilized ricin toxin vaccine, RiVax.
School closures due to the COVID-19 pandemic disrupted access to low or no-cost school breakfast and lunch programs for millions of low-income children.
As part of an initiative to give back to the cancer communities in the cities visited during its annual scientific meetings, the American Society for Radiation Oncology (ASTRO) is partnering with the Surviving And Moving Forward: The SAMFund for Young Adult Survivors of Cancer to raise awareness of cancer survivorship issues.
› Verified 4 days ago
| Entity Name | Excela Health Physician Practices, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821225202 PECOS PAC ID: 6204737117 Enrollment ID: O20040322001393 |
News Archive
Tianyin Pharmaceutical Co., Inc., a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine, branded generics and active pharmaceutical ingredients today announced the approval of the Company's operating subsidiary, Chengdu Tianyin Pharmaceutical Co., Ltd's application for the renewal of its High Tech Enterprise Status in Chengdu, Sichuan Province of China.
When will men have their own birth control pill? Scientists have been predicting the debut of a male pill within 5 years for the last 30 years. The factors accounting for that delay - and new optimism that a male pill will emerge within a decade - are the topic of a story in the current edition of Chemical & Engineering News. C&EN is the weekly newsmagazine of the American Chemical Society, the world's largest scientific society.
Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that the National Institute of Allergy and Infectious Diseases has exercised its option to advance the development of Soligenix's heat stabilized ricin toxin vaccine, RiVax.
School closures due to the COVID-19 pandemic disrupted access to low or no-cost school breakfast and lunch programs for millions of low-income children.
As part of an initiative to give back to the cancer communities in the cities visited during its annual scientific meetings, the American Society for Radiation Oncology (ASTRO) is partnering with the Surviving And Moving Forward: The SAMFund for Young Adult Survivors of Cancer to raise awareness of cancer survivorship issues.
› Verified 4 days ago
| Entity Name | Bpw Medical Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508820390 PECOS PAC ID: 7719878081 Enrollment ID: O20040324000830 |
News Archive
Tianyin Pharmaceutical Co., Inc., a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine, branded generics and active pharmaceutical ingredients today announced the approval of the Company's operating subsidiary, Chengdu Tianyin Pharmaceutical Co., Ltd's application for the renewal of its High Tech Enterprise Status in Chengdu, Sichuan Province of China.
When will men have their own birth control pill? Scientists have been predicting the debut of a male pill within 5 years for the last 30 years. The factors accounting for that delay - and new optimism that a male pill will emerge within a decade - are the topic of a story in the current edition of Chemical & Engineering News. C&EN is the weekly newsmagazine of the American Chemical Society, the world's largest scientific society.
Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that the National Institute of Allergy and Infectious Diseases has exercised its option to advance the development of Soligenix's heat stabilized ricin toxin vaccine, RiVax.
School closures due to the COVID-19 pandemic disrupted access to low or no-cost school breakfast and lunch programs for millions of low-income children.
As part of an initiative to give back to the cancer communities in the cities visited during its annual scientific meetings, the American Society for Radiation Oncology (ASTRO) is partnering with the Surviving And Moving Forward: The SAMFund for Young Adult Survivors of Cancer to raise awareness of cancer survivorship issues.
› Verified 4 days ago
| Entity Name | Southwestern Gastrointestinal Specialists Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235208950 PECOS PAC ID: 5395645683 Enrollment ID: O20080617000695 |
News Archive
Tianyin Pharmaceutical Co., Inc., a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine, branded generics and active pharmaceutical ingredients today announced the approval of the Company's operating subsidiary, Chengdu Tianyin Pharmaceutical Co., Ltd's application for the renewal of its High Tech Enterprise Status in Chengdu, Sichuan Province of China.
When will men have their own birth control pill? Scientists have been predicting the debut of a male pill within 5 years for the last 30 years. The factors accounting for that delay - and new optimism that a male pill will emerge within a decade - are the topic of a story in the current edition of Chemical & Engineering News. C&EN is the weekly newsmagazine of the American Chemical Society, the world's largest scientific society.
Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that the National Institute of Allergy and Infectious Diseases has exercised its option to advance the development of Soligenix's heat stabilized ricin toxin vaccine, RiVax.
School closures due to the COVID-19 pandemic disrupted access to low or no-cost school breakfast and lunch programs for millions of low-income children.
As part of an initiative to give back to the cancer communities in the cities visited during its annual scientific meetings, the American Society for Radiation Oncology (ASTRO) is partnering with the Surviving And Moving Forward: The SAMFund for Young Adult Survivors of Cancer to raise awareness of cancer survivorship issues.
› Verified 4 days ago
| Entity Name | Rgal Anesthesia Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699055251 PECOS PAC ID: 7517130602 Enrollment ID: O20111107000246 |
News Archive
Tianyin Pharmaceutical Co., Inc., a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine, branded generics and active pharmaceutical ingredients today announced the approval of the Company's operating subsidiary, Chengdu Tianyin Pharmaceutical Co., Ltd's application for the renewal of its High Tech Enterprise Status in Chengdu, Sichuan Province of China.
When will men have their own birth control pill? Scientists have been predicting the debut of a male pill within 5 years for the last 30 years. The factors accounting for that delay - and new optimism that a male pill will emerge within a decade - are the topic of a story in the current edition of Chemical & Engineering News. C&EN is the weekly newsmagazine of the American Chemical Society, the world's largest scientific society.
Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that the National Institute of Allergy and Infectious Diseases has exercised its option to advance the development of Soligenix's heat stabilized ricin toxin vaccine, RiVax.
School closures due to the COVID-19 pandemic disrupted access to low or no-cost school breakfast and lunch programs for millions of low-income children.
As part of an initiative to give back to the cancer communities in the cities visited during its annual scientific meetings, the American Society for Radiation Oncology (ASTRO) is partnering with the Surviving And Moving Forward: The SAMFund for Young Adult Survivors of Cancer to raise awareness of cancer survivorship issues.
› Verified 4 days ago
| Entity Name | Upmc Somerset |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1689296147 PECOS PAC ID: 1355235144 Enrollment ID: O20200609000137 |
News Archive
Tianyin Pharmaceutical Co., Inc., a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine, branded generics and active pharmaceutical ingredients today announced the approval of the Company's operating subsidiary, Chengdu Tianyin Pharmaceutical Co., Ltd's application for the renewal of its High Tech Enterprise Status in Chengdu, Sichuan Province of China.
When will men have their own birth control pill? Scientists have been predicting the debut of a male pill within 5 years for the last 30 years. The factors accounting for that delay - and new optimism that a male pill will emerge within a decade - are the topic of a story in the current edition of Chemical & Engineering News. C&EN is the weekly newsmagazine of the American Chemical Society, the world's largest scientific society.
Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that the National Institute of Allergy and Infectious Diseases has exercised its option to advance the development of Soligenix's heat stabilized ricin toxin vaccine, RiVax.
School closures due to the COVID-19 pandemic disrupted access to low or no-cost school breakfast and lunch programs for millions of low-income children.
As part of an initiative to give back to the cancer communities in the cities visited during its annual scientific meetings, the American Society for Radiation Oncology (ASTRO) is partnering with the Surviving And Moving Forward: The SAMFund for Young Adult Survivors of Cancer to raise awareness of cancer survivorship issues.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Marco Cantini, Po Box 229, 7th Floor, Latrobe, PA 15650-0229 Ph: () - | Marco Cantini, 121 W 2nd Ave, 7th Floor, Latrobe, PA 15650-1068 Ph: (724) 537-1230 |
News Archive
Tianyin Pharmaceutical Co., Inc., a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine, branded generics and active pharmaceutical ingredients today announced the approval of the Company's operating subsidiary, Chengdu Tianyin Pharmaceutical Co., Ltd's application for the renewal of its High Tech Enterprise Status in Chengdu, Sichuan Province of China.
When will men have their own birth control pill? Scientists have been predicting the debut of a male pill within 5 years for the last 30 years. The factors accounting for that delay - and new optimism that a male pill will emerge within a decade - are the topic of a story in the current edition of Chemical & Engineering News. C&EN is the weekly newsmagazine of the American Chemical Society, the world's largest scientific society.
Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that the National Institute of Allergy and Infectious Diseases has exercised its option to advance the development of Soligenix's heat stabilized ricin toxin vaccine, RiVax.
School closures due to the COVID-19 pandemic disrupted access to low or no-cost school breakfast and lunch programs for millions of low-income children.
As part of an initiative to give back to the cancer communities in the cities visited during its annual scientific meetings, the American Society for Radiation Oncology (ASTRO) is partnering with the Surviving And Moving Forward: The SAMFund for Young Adult Survivors of Cancer to raise awareness of cancer survivorship issues.
› Verified 4 days ago
Scott W. Berry, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 100 Excela Health Dr Ste 103, Latrobe, PA 15650 Phone: 724-804-1780 Fax: 724-804-1779 | |
Juei-ling Chang, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 121 W 2nd Ave, Latrobe, PA 15650 Phone: 724-537-1230 | |
Sherif A. Felix, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 121 W 2nd Ave, Latrobe, PA 15650 Phone: 724-537-1230 | |
Danielle Pavlik, Anesthesiology Medicare: Medicare Enrolled Practice Location: 121 W 2nd Ave, Latrobe, PA 15650 Phone: 724-537-1000 | |
Prasunamba N Nara, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 121 W 2nd Ave, Latrobe, PA 15650 Phone: 724-537-1230 |